Effect of glycerol-L-lactide coating polymer on bone ingrowth of bFGF-coated hydroxyapatite implants
- PMID: 15342184
- DOI: 10.1016/j.jconrel.2004.06.017
Effect of glycerol-L-lactide coating polymer on bone ingrowth of bFGF-coated hydroxyapatite implants
Abstract
Basic fibroblast growth factor (bFGF)-coated hydroxyapatite (HA) cylinders showed good bony incorporation in a previously conducted animal study. However, some cylinders exhibited focal inhomogeneous bone ingrowth. The purpose of the current study was to test whether glycerol-L-lactide polymer coating could improve release properties and bone incorporation of bFGF-coated HA implants. bFGF-coated HA cylinders with or without coating polymer were investigated for in vitro release of bFGF by an immuno-ligand-assay and also for bone ingrowth in miniature pigs after 42 and 84 days. Release from bFGF polymer composites was lower for the first 3 days compared to the other group but was more homogenous and detectable amounts were still found after 20 days. There was significant delay in bone ingrowth of the polymer implants in which even after 84 days bone ingrowth was not completed, whereas in the other group incorporation after 42 days occurred. Detailed histology revealed filling of the HA pores with the polymer, making ingrowth of the surrounding host bone impossible. Only after 84 days starting resorption of the polymer accompanied by bone ingrowth was found. The current study showed that glycerol-L-lactide is not suitable for coating of HA implants due to polymer induced "locking" of HA pores.
Similar articles
-
Glycerol-l-lactide coating polymer leads to delay in bone ingrowth in hydroxyapatite implants.J Control Release. 2005 Aug 18;106(1-2):154-61. doi: 10.1016/j.jconrel.2005.04.011. J Control Release. 2005. PMID: 15936110
-
Bone ingrowth in bFGF-coated hydroxyapatite ceramic implants.Biomaterials. 2003 Nov;24(25):4603-8. doi: 10.1016/s0142-9612(03)00354-5. Biomaterials. 2003. PMID: 12951003
-
Osseointegration of a hydroxyapatite-coated multilayered mesh stem.Biomaterials. 2004 Jul;25(15):2957-69. doi: 10.1016/j.biomaterials.2003.09.090. Biomaterials. 2004. PMID: 14967528
-
In vivo assessment of bone ingrowth potential of three-dimensional e-beam produced implant surfaces and the effect of additional treatment by acid etching and hydroxyapatite coating.J Biomater Appl. 2012 Mar;26(7):861-75. doi: 10.1177/0885328210391495. Epub 2011 Jan 27. J Biomater Appl. 2012. PMID: 21273261
-
Basic fibroblast growth factor for stimulation of bone formation in osteoinductive or conductive implants.Acta Orthop Scand Suppl. 1996 Apr;269:1-33. doi: 10.3109/17453679609155229. Acta Orthop Scand Suppl. 1996. PMID: 8629452 Review.
Cited by
-
Silica-chitosan hybrid coating on Ti for controlled release of growth factors.J Mater Sci Mater Med. 2011 Dec;22(12):2757-64. doi: 10.1007/s10856-011-4458-5. Epub 2011 Oct 16. J Mater Sci Mater Med. 2011. PMID: 22002514
-
Mineral coatings modulate β-TCP stability and enable growth factor binding and release.Acta Biomater. 2012 Mar;8(3):1117-24. doi: 10.1016/j.actbio.2011.11.028. Epub 2011 Dec 2. Acta Biomater. 2012. PMID: 22154864 Free PMC article.
-
Growth of hydroxyapatite coatings on biodegradable polymer microspheres.ACS Appl Mater Interfaces. 2009 Jul;1(7):1504-11. doi: 10.1021/am9001716. ACS Appl Mater Interfaces. 2009. PMID: 20161578 Free PMC article.
-
Bone mineral: A trojan horse for bone cancers. Efficient mitochondria targeted delivery and tumor eradication with nano hydroxyapatite containing doxorubicin.Mater Today Bio. 2022 Feb 26;14:100227. doi: 10.1016/j.mtbio.2022.100227. eCollection 2022 Mar. Mater Today Bio. 2022. PMID: 35265825 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources